E-NTPDases and ecto-5′-nucleotidase expression profile in rat heart left ventricle and the extracellular nucleotide hydrolysis by their nerve terminal endings

Life Sciences

Volumn 82, Issue 9-10, 2008, Pages 477-486

  Rücker, Bárbara ^a   Almeida, Manoela E ^a   Libermann, Towia A ^b   Zerbini, Luiz F ^b   Wink, Márcia R ^c   Sarkis, João J F ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^d NONE

Author keywords

Cardiac synaptosomes; E NTPDases; Ecto 5 nucleotidase CD73; Left ventricle

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE INHIBITOR; ADENOSINE TRIPHOSPHATE; ECTO 5' NUCLEOTIDASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; EVANS BLUE; GADOLINIUM CHLORIDE; LANTHANUM; LEVAMISOLE; MOLYBDIC ACID; NUCLEOTIDASE; OLIGOMYCIN; ORTHOVANADIC ACID; OUABAIN; SODIUM AZIDE; SURAMIN; TETRAMISOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFECT; ENZYME INHIBITION; HEART INFARCTION; HEART LEFT VENTRICLE; HYDROLYSIS; MALE; NERVE ENDING; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; GENE EXPRESSION PROFILING; HEART VENTRICLES; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; ISOENZYMES; KINETICS; MALE; MYOCARDIUM; NERVE ENDINGS; NUCLEOTIDES; OUABAIN; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SODIUM AZIDE; SURAMIN; SYNAPTOSOMES;

RATTUS; STROPHANTHUS GRATUS;

EID: 39149102144     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.12.003     Document Type: Article

References (63)

1. Aloyo V.J., McIlvain H.B., Bhavsar V.H., and Roberts J. Characterization of norepinephrine accumulation by a crude synaptosomal-mitochondrial fraction isolated from rat heart. Life Sciences 48 13 (1991) 1317-1324
2. Balas N., Arad M., Rabinowitz B., and Shainberg A. Modulation of cardiac A1-adenosine receptors in rats following treatment with agents affecting heart rate. Molecular and Cellular Biochemistry 231 1-2 (2002) 107-116
3. Belcher S.M., Zsarnovsky A., Crawford P.A., Hemani H., Spurling L., and Kirley T.L. Immunolocalization of ecto-nucleoside triphosphate diphosphohydrolase 3 in rat brain: implications for modulation of multiple homeostatic systems including feeding and sleep-wake behaviors. Neuroscience 137 4 (2006) 1331-1345
4. Benedict C.R., Shelton B., Johnstone D.E., Francis G., Greenberg B., Konstam M., Probstfield J.L., and Yusuf L. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 94 4 (1996) 690-697
5. Biederbick A., Kosan C., Kunz J., and Elsasserm H. First apyrase splice variants have different enzymatic properties. Journal of Biological Chemistry 275 25 (2000) 19018-19024
6. Bigonnesse F., Levesque S.A., Kukulski F., Lecka J., Robson S.C., Fernandes M.J., and Sévigny J. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43 18 (2004) 5511-5519
7. Borges F.P., Gottardi B., Stuepp C., Larre A.B., Tasca T., De Carli G.A., and Bonan C.D. Characterization of an ecto-5′-nucleotidase (EC 3.1.3.5) activity in intact trophozoites of Trichomonas gallinae. Veterinarian Parasitology 143 2 (2007) 106-111
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-254
9. Braunwald E., and Sobel B.E. Coronary blood flow and myocardial ischemia. In: Braunwald E. (Ed). Heart Disease, a Textbook of Cardiovascular Medicine (1988), W.B. Saunders, Philadelphia 1191-1221
10. Buffon A., Ribeiro V.B., Wink M.R., Casali E.A., and Sarkis J.J.F. Nucleotide metabolizing ecto-enzymes in Walker 256 tumor cells: molecular identification, kinetic characterization and biochemical properties. Life Sciences 80 10 (2007) 950-958
11. Burnstock G. Dual control of local blood flow by purines. Annals of the New York. Academy Sciences 603 (1990) 31-44
12. Burnstock G. Potential therapeutic targets in the rapidly expanding field of purinergic signaling. Clinical Medicine 2 1 (2002) 45-53
13. Casali E.A., Silva T.R., Gelain D.P., Kaiser G.R.R.F., Battastini A.M.O., Sarkis J.J.F., and Bernard E.A. Ectonucleotidase activities in Sertoli cells from immature rats. Brazilian Journal of Medical and Biological Research 34 10 (2001) 1247-1256
14. Chadwick B.P., and Frischauf A.M. Cloning and mapping of a human and mouse gene with homology to ecto-ATPase genes. Mamm Genome 8 9 (1997) 668-672
15. Chadwick B.P., and Frischauf A.M. The CD39-like gene family: identification of three new human members (CD39L2, CD39L3, and CD39L4), their murine homologues, and a member of the gene family from Drosophila melanogaster. Genomics 50 3 (1998) 357-367
16. + 2-ATPase activity. Analytical Biochemistry 157 2 (1986) 375-380
17. Escalada A., Navarro P., Ros E., Aleu J., Solsona C., and Martin-Satué M. Gadolinium inhibition of ecto-nucleotide triphosphate diphosphohydrolase activity in Torpedo electric organ. Neurochemical Research 29 9 (2004) 1711-1714
18. Fausther M., Lecka J., Kukulski F., Levesque S.A., Pelletier J., Zimmermann H., Dranoff J.A., and Sévigny J. Cloning, purification and identification of the liver canalicular ecto-ATPase as NTPDase8. American Journal of Physiology and Gastrointestinal Liver Physiology 292 3 (2006) G785-G795
19. Frasseto S.S., Dias R.D., and Sarkis J.J.F. Characterization of an ATP phyphosphohydrolase activity (APYRASE, EC 3.6.1.5) in rat blood platelets. Molecular and Cellular Biochemistry 129 1 (1993) 47-55
20. Fürstenau C.R., Trentin D.S., Barreto-Chaves M.L.M., and Sarkis J.J.F. Ecto-nucleotide pyrophosphatase/phosphodiesterase as part of a multiple system for nucleotide hydrolysis by platelets from rats: kinetic characterization and biochemical properties. Platelets 17 2 (2006) 84-91
21. Gendron F.P., Benrezzak O., Krugh B.W., Kong Q., Weisman G.A., and Beaudoin A.R. Purine signalling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Current Drug Targets 3 3 (2002) 229-245
22. Grover G.J., Atwal K.S., Sleph P.G., Wang F.-L., Monshizadegan H., Monticello T., and Green D.W. Excessive ATP hydrolysis in ischemic myocardium by mitochondrial F1Fo-ATPAse: effect of selective pharmacological inhibition of mitochondrial ATPase hydrolase activity. American Journal Physiology - Heart and Circulatory Physiology 287 4 (2004) H1747-H1755
23. Heine P., Braun N., Heilbronn A., and Zimmermann H. Functional characterization of rat ecto-ATPase and ecto-ATP diphosphohydrolase after heterologous expression in CHO cells. European Journal of Biochemistry 262 1 (1999) 102-107
24. Hicks-Berger C.A., Chadwick B.P., Frischauf A.M., and Kirley T.L. Expression and characterization of soluble and membrane-bound human nucleoside triphosphate diphosphohydrolase 6 (CD39L2). The Journal of Biological Chemistry 275 44 (2000) 34041-34045
25. Kegel B., Braun N., Heine P., Maliszewski C.R., and Zimmermann H. An ecto-ATPase and an ecto-ATPdiphosphohydrolase are expressed in rat brain. Neuropharmacology 36 9 (1997) 1189-1200
26. Knowles A.F., and Nagy A.K. Inhibition of an ecto-ATP-diphosphohydrolase by azide. European Journal of Biochemistry 262 2 (1999) 349-357
27. Knowles A.F., Nagy A.K., Strobel R.S., and Wu-Weis M. Purification, characterization, cloning and expression of the chicken liver ecto-ATP dyphosphohydrolase. European Journal of Biochemistry 269 9 (2002) 2373-2382
28. 2 receptor subtypes in the cardiovascular system. Biochemical Journal 336 3 (1998) 513-523
29. Leal D.B.R., Streher C.A., Neu T.N., Bittencourt F.P., Leal C.A.M., Silva J.E.P., Morsch V.M., and Schetinger M.R. Characterization of an NTPDase (NTPDase1; ecto-apyrase; ecto-diphophohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes. Biochemistry et Biophysica Acta 1721 1-3 (2005) 9-15
30. Lemmens R., Vanduffel L., Kittel A., Beaudoin A.R., Benrezzak O., and Sévigny J. Distribution, cloning and characterization of porcine nucleoside triphosphate diphosphohydrolase-1. European Journal of Biochemistry 267 13 (2000) 4106-4114
31. Machida T., Heerdt P.M., Reid A.C., Schafer U., Silver R.B., Broekaman M.J., Marcus A.J., and Levi R. Ectonucleoside triphosphate diphosphohydrolase1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis. The Journal of Pharmacology and Experimental Therapeutics 313 2 (2005) 570-577
32. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., Olson K.M., Islam N., Pinsky D.J., and Levi R. Role of CD39 (NTPDase1) in thromboregulation, cerebroprotection and cardioprotection. Seminars in Thrombosis and Hemostasis 31 2 (2005) 234-246
33. Mihaylova-Todorova S., Todorov L.D., and Westfall D.P. Enzyme kinetics and pharmacological characterization of nucleotidases released from the guinea pig isolated vas deferens during nerve stimulation: evidence for a soluble ecto-nucleoside triphosphate diphosphohydrolase-like ATPase and a soluble ecto-5′-nucleotidase-like AMPase. The Journal of Pharmacology and Experimental Therapeutics 302 3 (2002) 992-1001
34. Mulero J.J., Yeung G., Nelken S.T., and Ford J.E. CD39-L4 is a secreted human apyrases, specific for the hydrolysis of diphosphates. The Journal of Biological Chemistry 274 29 (1999) 20064-20067
35. Naito Y., and Lowenstein J.M. 5′-nucleotidase from rat heart. Biochemistry 20 18 (1981) 5188-5194
36. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sciences 71 18 (2002) 2083-2103
37. Oliveira E.M., Battastini A.M.O., Meirelles M.N.L., Moreira C.M., Dias R.D., and Sarkis J.J.F. Characterization and localization of an ATP dyphosphohydrolase activity (EC 3.6.1.5) in sarcolemmal membrane from rat heart. Molecular and Cellular Biochemistry 170 (1997) 115-123
38. Oses J.P., Cardoso C.M., Germano R.A., Kirst I.B., Rucker B., Furstenau C.R., Wink M.R., Bonan C.D., Battastini A.M.O., and Sarkis J.J.F. Soluble NTPDase: an additional system of nucleotide hydrolysis in rat blood serum. Life Sciences 74 26 (2004) 3275-3284
39. Plesner L. Ecto-ATPases: identities and functions. International Review of Citology. 158 (1995) 141-214
40. Ralevic V., and Burnstock G. Roles of P2-purinoceptors in the cardiovascular system. Circulation 84 1 (1991) 1-14
41. Ralevic V., and Burnstock G. Involvement of purinergic signalling in cardiovascular diseases. Drug News Perspective 16 3 (2003) 133-140
42. Richardt G., Waas W., Kranzhöfer R., Mayer E., and Schömig A. Adenosine inhibits exocytotic release of endogenous noradrenaline in rat heart: a protective mechanism in early myocardial ischemia. Circulation Research 61 1 (1987) 117-123
43. Robson S., Sévigny J., and Zimmermann H. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signalling 2 (2006) 409-430
44. Rucker B., Almeida M.E., Libermann T.A., Zerbini L.F., Wink M.R., and Sarkis J.J.F. Biochemical characterization of ecto-nucleotide pyrosphosphatase/phopshodiesterase (E-NPP, E.C. 3.1.4.1) from rat heart left ventricle. Molecular and Cellular Biochemistry 306 1-2 (2007) 247-254
45. Sasaki N., Sato T., Marban E., and O'Rourke B. ATP consumption by uncoupled mitochondria activates sarcolemmal K (ATP) channels in cardiac myocytes. American Journal Physiology - Heart and Circulatory Physiology. 280 4 (2001) H1882-H1888
46. Sesti C., Broekman M.J., Drosopoulos J.H.F., Islam N., Marcus A.J., and Levi R. Ectonucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. The Journal of Pharmacology and Experimental Therapeutics 300 2 (2002) 605-609
47. Sethi R., Dhalla K.S., Beamish R.E., and Dhalla N.S. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. American Journal of Physiology 272 2 (1997) H884-H893
48. Sévigny J., Sundberg C., Braun N., Guckelberger O., Czismadia E., Qawi I., Imai M., Zimmermann H., and Robson S. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99 8 (2002) 2801-2809
49. Shryock J.C., and Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. The American Journal of Cardiology 79 12A (1997) 2-10
50. Smith T.M., and Kirley T.L. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases. Biochimica et Biophysica Acta 1386 1 (1998) 65-78
51. Todorov L.D., Mihaylova-Todorova S., Westfall T.D., Sneddon P., Kennedy C., Bjur R.A., and Westfall D.P. Neuronal release of soluble ectonucleotidases and their role in neurotransmitter inactivation. Nature 387 6628 (1997) 76-79
52. Vassort G. Adenosine 5′-triphosphate: a P2-Purinergic agonist in the myocardium. Physiological Reviews 81 2 (2001) 767-806
53. Vollmayer P., Koch M., Braun N., Heine P., Servos J., Israr E., Kegelm B., and Zimmermann H. Multiple ecto-nucleotidases in PC-12 cells: identification and cellular distribution after heterologous expression. Journal of Neurochemistry 78 5 (2001) 1019-1028
54. Wang T.F., and Guidotti G. Golgi localization and functional expression of human uridine diphosphatase. The Journal of Biological Chemistry 273 18 (1998) 11392-11399
55. Wink M.R., Braganhol E., Tamajusuku A.S.K., Casali E.A., Karl J., Barreto-Chaves M.L., Sarkis J.J.F., and Battastini A.M.O. Extracellular adenine nucleotides metabolism in astrocyte cultures from different brain regions. Neurochemistry International 43 7 (2003) 621-628
56. Wink M., Braganhol E., Tamajusuku A.S.K., Lenz G., Zerbini L.F., Libermann T.A., Sévigny J., Battastini A.M.O., and Robson S.C. Nucleoside triphosphate diphosphohydrolase-2 (NTPDAse2/CD39L1) is the dominant ectonucleotidases expressed by rat astrocytes. Neuroscience 138 2 (2006) 421-432
57. Wink M.R., Lenz G., Braganhol E., Tamajusuku A.S., Schwartsmann G., Sarkis J.J.F., and Battastini A.M.O. Altered extracellular ATP, ADP and AMP catabolism in glioma cell lines. Cancer Letters. 198 2 (2003) 211-218
58. Yeung G., Mulero J.J., McGowan D.W., Bajwa S.S., and Ford J.E. CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart. Biochemistry 39 42 (2000) 12916-12923
59. Zerbini L.F., Wang Y., Cho J.Y., and Libermann T.A. Constitutive activation of nuclear factor kB p50/p65 and Fra-1 and junD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Research 63 9 (2003) 2206-2215
60. Zimmermann H. 5′-nucleotidase: molecular structure and functional aspects. Biochemical Journal 285 2 (1992) 345-365
61. Zimmermann H. Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system. Progress in Neurobiology 49 6 (1996) 589-618
62. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg's Archives of Pharmacology 362 4-5 (2000) 299-309
63. Zimmermann H. Ectonucleotidases: some developments and a note on nomenclature. Drug Development Research 52 (2001) 44-56